AAAAAA

   
Results: 1-19 |
Results: 19
Dyslipidemia and renal disease: pathogenesis and clinical consequences
Authors: Wanner, C Quaschning, T
Citation: C. Wanner et T. Quaschning, Dyslipidemia and renal disease: pathogenesis and clinical consequences, CURR OP NEP, 10(2), 2001, pp. 195-201
Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension
Authors: Quaschning, T D'Uscio, LV Shaw, S Grone, HJ Ruschitzka, F Luscher, TF
Citation: T. Quaschning et al., Vasopeptidase inhibition restores renovascular endothelial dysfunction in salt-induced hypertension, J AM S NEPH, 12(11), 2001, pp. 2280-2287
Vasopeptidase inhibitors - concepts and evidence
Authors: Ruschitzka, F Corti, R Quaschning, T Hermann, M Luscher, TF
Citation: F. Ruschitzka et al., Vasopeptidase inhibitors - concepts and evidence, NEPH DIAL T, 16(8), 2001, pp. 1532-1535
Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension
Authors: Quaschning, T d'Uscio, LV Shaw, S Viswambharan, H Ruschitzka, FT Luscher, TF
Citation: T. Quaschning et al., Chronic vasopeptidase inhibition restores endothelin-converting enzyme activity and normalizes endothelin levels in salt-induced hypertension, NEPH DIAL T, 16(6), 2001, pp. 1176-1182
Influence of aldosterone vs endothelin receptor antagonism on renovascularfunction in liquorice-induced hypertension
Authors: Quaschning, T Ruschitzka, F Niggli, B Lunt, CMB Shaw, S Christ, M Wehling, M Luscher, TF
Citation: T. Quaschning et al., Influence of aldosterone vs endothelin receptor antagonism on renovascularfunction in liquorice-induced hypertension, NEPH DIAL T, 16(11), 2001, pp. 2146-2151
Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease
Authors: Quaschning, T Krane, V Metzger, T Wanner, C
Citation: T. Quaschning et al., Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease, AM J KIDNEY, 38(4), 2001, pp. S14-S19
Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension
Authors: Quaschning, T d'Uscio, LV Shaw, S Luscher, TF
Citation: T. Quaschning et al., Vasopeptidase inhibition exhibits endothelial protection in salt-induced hypertension, HYPERTENSIO, 37(4), 2001, pp. 1108-1113
Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension
Authors: Quaschning, T Ruschitzka, F Shaw, S Luscher, TF
Citation: T. Quaschning et al., Aldosterone receptor antagonism normalizes vascular function in liquorice-induced hypertension, HYPERTENSIO, 37(2), 2001, pp. 801-805
Vasopeptidase inhibition prevents endothelial dysfunction of resistance arteries in salt-sensitive hypertension in comparison with single ACE inhibition
Authors: d'Uscio, LV Quaschning, T Burnett, JC Luscher, TF
Citation: Lv. D'Uscio et al., Vasopeptidase inhibition prevents endothelial dysfunction of resistance arteries in salt-sensitive hypertension in comparison with single ACE inhibition, HYPERTENSIO, 37(1), 2001, pp. 28-33
Endothelin 1 type A receptor antagonism prevents vascular dysfunction and hypertension induced by 11 beta-hydroxysteroid dehydrogenase inhibition - Role of nitric oxide
Authors: Ruschitzka, F Quaschning, T Noll, G deGottardi, A Rossier, MF Enseleit, F Hurlimann, D Luscher, TF Shaw, SG
Citation: F. Ruschitzka et al., Endothelin 1 type A receptor antagonism prevents vascular dysfunction and hypertension induced by 11 beta-hydroxysteroid dehydrogenase inhibition - Role of nitric oxide, CIRCULATION, 103(25), 2001, pp. 3129-3135
Vasopeptidase inhibitors: clinical implications of a new class of drugs
Authors: Quaschning, T Corti, R Ruschitzka, FT Noll, C Luscher, TF
Citation: T. Quaschning et al., Vasopeptidase inhibitors: clinical implications of a new class of drugs, DEUT MED WO, 125(16), 2000, pp. 499-503
Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin
Authors: Ruschitzka, FT Wenger, RH Stallmach, T Quaschning, T de Wit, C Wagner, K Labugger, R Kelm, M Noll, G Rulicke, T Shaw, S Lindberg, RLP Rodenwaldt, B Lutz, H Bauer, C Luscher, TF Gassmann, M
Citation: Ft. Ruschitzka et al., Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin, P NAS US, 97(21), 2000, pp. 11609-11613
Enhanced peroxynitrite formation is associated with vascular aging
Authors: van der Loo, B Labugger, R Skepper, JN Bachschmid, M Kilo, J Powell, JM Palacios-Callender, M Erusalimsky, JD Quaschning, T Malinski, T Gygi, D Ullrich, V Luscher, TF
Citation: B. Van Der Loo et al., Enhanced peroxynitrite formation is associated with vascular aging, J EXP MED, 192(12), 2000, pp. 1731-1743
The role of the endothelium in the development and treatment of vascular disease
Authors: Quaschning, T Ruschitzka, FT Maier, W Luscher, TF
Citation: T. Quaschning et al., The role of the endothelium in the development and treatment of vascular disease, INTERNIST, 41(4), 2000, pp. 355-362
Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease
Authors: Ruschitzka, F Moehrlen, U Quaschning, T Lachat, M Noll, G Shaw, S Yang, ZH Teupser, D Subkowski, T Turina, MI Luscher, TF
Citation: F. Ruschitzka et al., Tissue endothelin-converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease, CIRCULATION, 102(10), 2000, pp. 1086-1092
Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients
Authors: Quaschning, T Schomig, M Keller, M Thiery, J Nauck, M Schollmeyer, P Wanner, C Kramer-Guth, A
Citation: T. Quaschning et al., Non-insulin-dependent diabetes mellitus and hypertriglyceridemia impair lipoprotein metabolism in chronic hemodialysis patients, J AM S NEPH, 10(2), 1999, pp. 332-341
The role of Chlamydia in coronary heart disease - fact or fiction?
Authors: Quaschning, T Wanner, C
Citation: T. Quaschning et C. Wanner, The role of Chlamydia in coronary heart disease - fact or fiction?, NEPH DIAL T, 14(12), 1999, pp. 2800-2803
Immunosuppression enhances atherogenicity of lipid profile after transplantation
Authors: Quaschning, T Mainka, T Nauck, M Rump, LC Wanner, C Kramer-Guth, A
Citation: T. Quaschning et al., Immunosuppression enhances atherogenicity of lipid profile after transplantation, KIDNEY INT, 56, 1999, pp. S235-S237
Abnormalities in lipoprotein metabolism in hemodialysis patients
Authors: Koniger, M Quaschning, T Wanner, C Schollmeyer, P Kramer-Guth, A
Citation: M. Koniger et al., Abnormalities in lipoprotein metabolism in hemodialysis patients, KIDNEY INT, 56, 1999, pp. S248-S250
Risultati: 1-19 |